Ran Qin
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Regional Heterogeneity in Screen Time and Usage Habits Associated with Insufficient Hyperopic Reserve in Schoolchildren - 9 PLADs, China, 2020-2024.
Journal: China CDC weekly
Published: July 30, 2025
Predicting Cycloplegic Spherical Equivalent Refraction Among Children and Adolescents Using Non-cycloplegic Data and Machine Learning - China, 2020-2024.
Journal: China CDC weekly
Published: July 24, 2025
Current Status of Hyperopic Reserve Among Children and Adolescents - 10 PLADs, China, 2020-2024.
Journal: China CDC weekly
Published: June 20, 2025
Reference values of spherical equivalent for predicting the onset and progression of myopia among children and adolescents in China.
Journal: The British journal of ophthalmology
Published: November 11, 2024
Reference Values of Non-Cycloplegic Spherical Equivalent for Screening and Predicting Myopia Among Children and Adolescents - China, 2020-2024.
Journal: China CDC weekly
Published: October 17, 2024
Integrating multi-omics methods for personalized treatment of refractory chronic myelomonocytic leukemia with NRAS and TET2 mutations.
Journal: Cancer pathogenesis and therapy
Published: September 26, 2024
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1+CD8+ T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer.
Journal: Cancer research communications
Published: March 18, 2023
Diagnostic Efficacy of 18F-FDG PET/CT in Detecting Bone Marrow Infiltration in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Journal: Biomedical and environmental sciences : BES
Published: February 07, 2023
Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors.
Journal: Frontiers in bioengineering and biotechnology
Published: August 25, 2022
Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient.
Journal: Immunotherapy
Published: April 21, 2022
Last Updated: 09/26/2026